Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection

Article Abstract:

Cigarette smoking by HIV-infected patients appears to lower the risk of certain opportunistic infections and raise the risk of others. Researchers studied the effects of smoking in 3,221 HIV-positive men and women. Overall, 57% were smokers, 19% were former smokers and 24% had never smoked. There was no significant difference overall in the incidence of opportunistic infections between smokers and nonsmokers. However, smokers had a higher risk of pneumonia, oral candidiasis and AIDS dementia. They had a lower risk of Kaposi's sarcoma and other diseases outside the respiratory tract.

Author: Neaton, James D., Burns, David N., Sherer, Renslow, Gordin, Fred M., Capps, Linnea, Mitchell, Thomas, Hillman, David, Vallier, William G., Thurnherr, Michael D.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1996
Health aspects, Complications and side effects, Risk factors, HIV infection, HIV infections, Smoking, Pneumonia, Opportunistic infections

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of Rhesus monkeys against productive simian immunodeficiency virus infection or disease development

Article Abstract:

A vaccine made of gp130 oligomers from the sivian immunodeficiency virus (SIV) appears to be effective in protecting Rhesus monkeys from SIV infection. SIV is a virus similar to HIV that infects monkeys and creates a disease similar to AIDS. Researchers vaccinated Rhesus monkeys with a vaccine made from SIV gp130 oligomers or one made from SIV gp130 monomers. Then the monkeys were infected with SIV, as was a group of monkeys that were not vaccinated. Only the monkeys vaccinated with SIV gp130 oligomers were protected from infection.

Author: Jones, David, Fuchs, Dietmar, Wachter, Helmut, Petry, Harald, Dittmer, Ulf, Farrar, Graham, Nisslein, Thomas, Jurkiewicz, Elke, Hunsmann, Gerhard, Stahl-Hennig, Christiane, Luke, Wolfgang
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1998
Testing, AIDS vaccines, Simian immunodeficiency virus

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Plasma adenosine deaminase2: a marker for human immunodeficiency virus infection. Reasons for modification of genetic highly active antiretroviral therapeutic regimens among patients in southern India
  • Abstracts: Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. NIH conference: development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection
  • Abstracts: Meconium-stained amniotic fluid: a risk factor for microbial invasion of the amniotic cavity. The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy
  • Abstracts: CD4+ monocyte counts in persons with HIV-1 infection: an early increase is followed by a progressive decline. Comparison of spinal fluid beta2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.